PAMA laboratory reimbursement cuts delayed through 2024
PAMA Reporting Delayed Again as Permanent Fix Sought Labs received a welcome reprieve from looming Clinical Lab Fee Schedule (CLFS) cuts this month when Protecting Access to Medicare Act (PAMA) reporting and associated test reimbursement reductions were delayed until...
Unpacking the Billing Mystery of the GI Panel
By: Dyana Williams, Client Engagement, Lighthouse RCM Solutions The following is a case study of a Gastrointestinal (GI) panel billing issue we helped a client navigate. The blog takes a light-hearted approach and unpacks the problem in the format of classic...
Examining Common Denial Reasons for Drug Screenings
By: Dyana Williams, Client Engagement Manager, Lighthouse RCM Solutions Presumptive drug testing screens for drug presence, while definitive testing identifies specific drugs and concentrations. Both aid in patient care and treatment decisions. In the world of...
CMS to Withdraw NCCI Edit Impacting Drug Testing
CMS is withdrawing NCCI PTP edits between Column One codes 80305, 80306, and 80307 for presumptive test(s), and Column Two codes G0480 – G0483, and G0659 for definitive test(s), according to an announcement posted on the agency’s website and communications from...